FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,056 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 3200 - 3400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1146.664Congenital Zika Syndromes (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.665Congenital Zika Syndromes (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.666Guillain Barré syndrome (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.668Rash (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.671Fever (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.672Arthralgia (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.673Arthralgia (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.674Conjunctivitis (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.675Conjunctivitis (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.676Pregnant (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.677Postpartum (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.678Postpartum (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.679Hearing Loss (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.680Abdominal Pain (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.681Abdominal Pain (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.686Erythema Multiforme (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.687Myalgia (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.689Periorbital Edema (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.691Eosinophilia (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.692Eosinophilia (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.70Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.702Weight Loss (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.705Syphilis (Tests for Treponemal or Non Treponemal Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.709Cough [Non Productive] (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.71Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.711Wound Infection (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.712Pneumonia (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.713Sepsis [Septicemia] [Unspecified Organism] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.714Sepsis [Septicemia] [Unspecified Organism] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.715Meningitis (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.717Cellulitis (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.718Cellulitis (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.719Myositis [Unspecified Cause] (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.720Myositis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.721Otitis Media (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.722Otitis Media (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.723Otitis Externa (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.724Otitis Externa (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.727Acute Upper Respiratory Illness (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.728HIV Infection (Tests for HIV Nucleic Acid [Qualitative])active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.730HIV Infection (Tests for HIV Antibody)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.733Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.744Coccidioidomycosis (Tests for Coccidioides species IgG Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.746Treponema pallidum (Tests by Microscopic Observation)active2022-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.750Chest Pain (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.755Acute Upper Respiratory Illness (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.756Purpura (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.757Muscle Spasms (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.758Muscle Spasms (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.762Mumps (Test Panels for mumps virus IgM IgG Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.763Parotitis [Unspecified Cause] (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.764Mumps (Tests for mumps virus IgG Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.765Aseptic Meningitis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.766Encephalitis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.767Hearing Loss (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.770Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.773Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.777Mastitis (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.779Pancreatitis (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.780Pancreatitis (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.782Rubella (Test Panels for rubella virus IgM IgG Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.785Opioid Overdose and Poisoning (Tests for Opioids [Qualitative])active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.789Purpura (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.79Campylobacteriosis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.792Novel Influenza A Virus Infection (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.793Novel Influenza A Virus Infection (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.794Sore Throat (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.795Influenza (influenza A virus in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.796Influenza (Novel influenza A virus in Lab Results)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.797Influenza (Tests for influenza A or B virus by Culture and Identification Method)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.798Influenza (Tests for influenza A virus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.799Influenza (Tests for influenza A virus Antigen)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.802Influenza (Tests for Novel influenza A virus Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.803Tests by Microscopic Observation in Tissue by H&E or PAS Stainactive2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.808Headache (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.809Headache (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.810Backache (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.811Backache (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.815NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative])active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.816Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.818Measles (Tests for measles virus IgG Antibody [Ratio] in Serum)active2025-03ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.820Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.822Pneumoconiosis (Unspecified) (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.823Pneumoconiosis (Unspecified) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.824Computerized Tomography of Chest (Imaging)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.830Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.835Lead in Blood (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.836Lead in Blood (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.839Acid Fast Bacilli (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.841Tuberculosis (Interferon Gamma Release Assays)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.842Tests by Microscopic Observation in Tissueactive2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.846SARS (Tests for SARS_CoV by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.847SARS (Tests for SARS_CoV Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.86Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.864Nausea (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.865Confusion (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.867Dyspnea (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.869Loss of Consciousness (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.87Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.875SARS (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.878MERS (Tests for MERS_CoV Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.88Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.881Difficulty Breathing (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.884Tests by Microscopic Observation in Bloodactive2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.889Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.892Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.895Rhinorrhea (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.896Tests by Microscopic Observation in Blood Smearactive2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.897Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.9Xray of Chest (Imaging)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.90Cough (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.902Acute Renal Failure [Unspecified Cause] (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.907Arthritis [Unspecified Cause] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.91Cough (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.910Epididymitis [Unspecified Cause] (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.911Epididymitis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.914Osteomyelitis [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.915Osteomyelitis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.918Spondylitis [Unspecified Cause] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.919Arthritis [Unspecified Cause] (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.92Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.927Thrombocytopenia [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.928Bleeding [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.930ECG Abnormalities [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.931Hematemesis [Unspecified Cause] (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.932Hematemesis [Unspecified Cause] (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.934Hematuria [Unspecified Cause] (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.935Hemoptysis (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.937Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.942Petechiae [Non Traumatic] (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.952Thrombocytopenia [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.956Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.957Regional Lymphadenitis [Including Bubo] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.958Regional Lymphadenitis (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.965Proteinuria [Unspecified Cause] (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.969Proteinuria [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.970Bulbar Weakness (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.971Bulbar Weakness (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.976Dysphagia (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.978Impaired Respiration [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.979Botulism (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.98Shigellosis (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.989Tests for Mycobacterium species by Culture and Identification Methodactive2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.994Organisms (Tests for Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.998Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.999Chlamydia species (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.109Pressure Injury Stage 2, 3, 4 or Unstageableactive2023-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1147.110Pressure Injury Stage 2, 3, 4 or Unstageableactive2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.112Pressure Injury Deep Tissueactive2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.113Pressure Injury Stage 2, 3, 4 or Unstageableactive2022-04ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1147.122Inpatient Fallsactive2021-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.130Anticoagulants for VTE Prophylaxisactive2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1147.131Anticoagulants for Indications Other than VTE Prophylaxisactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1147.160Abdominal or Pelvic CT Scan with Contrastactive2024-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1147.163Ultrasound of Lower Extremitiesactive2024-08ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.164Ultrasound of Lower Extremitiesactive2024-08ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1147.165Ultrasound of Lower Extremitiesactive2024-08ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1147.171Inpatient Fallsactive2021-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1147.183Anti Factor Xa Assayactive2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1147.187Extracorporeal Membrane Oxygenation (ECMO)active2022-04ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1147.188Extracorporeal Membrane Oxygenation (ECMO)active2022-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.190Intra Aortic Balloon Pumpactive2022-04ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1147.191Intra Aortic Balloon Pumpactive2022-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1147.193Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)active2022-04ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1147.194Pressure Injury Deep Tissue Diagnosesactive2022-04ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1147.196Pressure Injury Stage 2, 3, 4, or Unstageable Diagnosesactive2022-04ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1147.197Present on Admission or Clinically Undeterminedactive2022-04ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1147.198Not Present On Admission or Documentation Insufficient to Determineactive2022-04ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1151.1DEXA Dual Energy Xray Absorptiometry, Bone Densityactive2016-07ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1151.11Bladder Cancer Staging Ta for Urology Careactive2016-07ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.12Bladder Cancer staging T1 for Urology Careactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.13Bladder Cancer staging Tis for Urology Careactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.15Carcinoma of urinary bladder, superficialactive2016-07ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.16Injection Leuprolide Acetateactive2017-08ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1151.17High grade bladder cancer Ta for Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.18Immunocompromised state for Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.19Systemic chemotherapy for urology careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.2Bladder Cancer in Situactive2016-07ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1151.20Corticosteroids for patients receiving Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.21Calcineurin inhibitors for patients receiving Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.23Immunomodulators for patients undergoing Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.24Monoclonal antibody for patient undergoing Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.28Radiotherapy for patients undergoing Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.29Plasmacytoid cell, morphologic abnormality for urology careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.3Bladder Cancer in Situactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1151.30Sarcomatoid, morphologic abnormality for Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.31Micropapillary, morphologic abnormality, for Urology Careactive2017-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.32Immunosuppressive Drugs for Urology Careactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1151.38DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Careactive2017-08ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1151.39Mixed histology urothelial cell carcinoma for Urology Careactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.4BCG Bacillus Calmette Guerin, Ticeactive2016-07ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1151.40Cystectomy for Urology Careactive2017-03ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.44Unavailability of Bacillus Calmette Guerin for urology careactive2017-03ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1151.45Bladder Cancer for Urology Careactive2017-03ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1151.48Androgen deprivation therapy for Urology Careactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1151.5BCG Bacillus Calmette Guerin, Connaughtactive2016-07ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1151.52BCG Bacillus Calmette Guerin for Urology Careactive2020-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1151.53Cystectomy for Urology Careactive2018-04ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1151.54Acute Tuberculosis for Urology Careactive2018-04ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1151.55Cystectomy for Urology Careactive2022-03ushl7vsac